BioWorld-International-2009-04-01
Intercell Gets Stock Boost as FDA Approves Ixiaro
Intercell Gets Stock Boost as FDA Approves Ixiaro
Shares in Intercell AG received a significant boost Tuesday on news that the FDA approved its Japanese Encephalitis Virus (JEV) vaccine Ixiaro late Monday. (BioWorld International)

